**Study Objective:** This study tests how well a special cream called **ruxolitinib** works and how safe it is for kids aged 6 to 17 with moderate **atopic dermatitis** (a type of eczema).
**Key Terms:**
- **Ruxolitinib:** A medicine in cream form used to treat skin conditions.
- **Atopic Dermatitis (AD):** A skin condition causing itchy, red, and swollen skin.
- **EASI & IGA Scores:** Tools doctors use to measure the severity of atopic dermatitis.
- **TCS & TCI:** Types of medications usually used to treat eczema.
**Eligibility:**
- Participants must be 6 to 17 years old.
- Must have had eczema for at least 3 months or 2 years, depending on age.
- Need to have a certain severity of eczema at the start.
**Key Points:**
- **Study Duration:** Participants will need to stop other eczema treatments during the study.
- **Safety Measures:** Females who have started menstruating must have a negative pregnancy test.
- **Commitment:** Participants will need to attend multiple visits and follow specific study rules.
This study aims to see if this cream can provide relief for kids with moderate eczema while ensuring their safety.
How understandable was the trial content above?
Hard to understand
Easy to understand